Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
URGN
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -12.7%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
urogen
pharma
class
action
investors
nasdaq
lawsuit
against
securities
after
filed
firm
drug
contact
bragar
eagel
squire
about
price
been
URGN
UroGen Pharma Ltd. Ordinary Shares
StonvexStonvexStonvexStonvex